-transparent.png){kind=logo}
In a series of 96 patients with membranous glomerulonephritis (MGN) there were 14 who had concomitant rheumatoid arthritis. Ten of these had been treated with gold or D-penicillamine; in four patients neither of these drugs could have been responsible for the MGN. One of them received intrasynovial osmium tetroxide two months before the clinical onset of MGN. Three of the patients had positive rheumatoid factor. HLA-type was examined in three patients and all showed B27 antigen but not DR3. No patient developed signs of systemic lupus erythematosus during the follow-up (mean 5.9 years). In two patients MGN persisted as judged from urinary abnormalities, one patient recovered after a relapse period and one developed secondary amyloidosis.
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
September 1985,
Clinical nephrology,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
July 1996,
Clinical rheumatology,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
June 1987,
Annals of the rheumatic diseases,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
March 1992,
Nihon rinsho. Japanese journal of clinical medicine,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
November 1974,
Annals of the rheumatic diseases,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
August 1982,
Arthritis and rheumatism,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
October 1987,
The Journal of rheumatology,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
March 1982,
The American journal of medicine,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
June 1991,
Nihon Jinzo Gakkai shi,
E Honkanen, and
T Törnroth, and
E Pettersson, and
B Skrifvars
February 1985,
Ryumachi. [Rheumatism],
